Apimeds Pharmaceuticals US Plans $20 Million IPO for Week of February 24th (APUS)
Apimeds Pharmaceuticals US (APUS) is planning to raise $20 million in an initial public offering on the week of February 24th, IPO Scoop reports. The company will be issuing 4,500,000 shares at $4.00-$5.00 per share. The company has a market-cap of $57.1 million. D. Boral Capital (ex-EF Hutton) served as the underwriter for the IPO. […]
Apimeds Pharmaceuticals US (APUS) is planning to raise $20 million in an initial public offering on the week of February 24th, IPO Scoop reports. The company will be issuing 4,500,000 shares at $4.00-$5.00 per share. The company has a market-cap of $57.1 million. D. Boral Capital (ex-EF Hutton) served as the underwriter for the IPO. […]
